Abstract
We recently developed an animal model of hyperglycaemia during pregnancy to investigate the molecular mechanisms underlying cardiac abnormalities observed in infants of diabetic mothers (IDMs). Furthermore, we explored the diet that should be consumed to improve the abnormalities by a molecular nutritional study and investigated the potential molecular pathway for this effect in the animal model. Assessment of newborn rat hearts revealed that altered insulin signalling-induced insulin resistance by inhibiting the Akt/mammalian target of rapamycin (mTOR) pathway, which was improved in the offspring of rats that were fed a fish oil-rich diet. Here, we describe the significance of consuming fish oil during pregnancy in the first section of this chapter. The second section deal with the potential molecular pathways involved in EPA-mediated regulation of cardiac function. Studies have demonstrated that intrauterine foetal exposure to hyperglycaemia during pregnancy was associated with cardiovascular complications, such as cardiomyocyte hypertrophy, in infants of diabetic mothers (IDMs). We recently developed an animal model of hyperglycaemia during pregnancy to investigate the molecular mechanisms underlying cardiac abnormalities observed in IDMs. Furthermore, we explored the diet that should be consumed to improve the abnormalities by a molecular nutritional study and investigated the potential molecular pathway for this effect in the animal model. Assessment of newborn rat hearts revealed that altered insulin signalling-induced insulin resistance by inhibiting the Akt/mammalian target of rapamycin (mTOR) pathway, which was improved in the offspring of rats that were fed a fish oil-rich diet. Nevertheless, specific ingredients of fish oil that are responsible for improving abnormal insulin signalling remain unclear. Fish oil is present in many types of seafood, particularly fatty fish, and contains high docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) levels, both of which are omega-3 polyunsaturated fatty acids (PUFAs). Consuming fish oil lowers plasma triglyceride levels, resting heart rate and blood pressure and reduces inflammation and improves vascular function. Consuming EPA is also associated with improvements in patients with cardiovascular diseases. Here, we describe the significance of consuming fish oil during pregnancy in the first section of this chapter. The second section examines the potential molecular pathways involved in EPA-mediated regulation of cardiac function. EPA influences a myriad of molecular signalling pathways by altering the functions of key enzymes via membrane and nuclear receptors and transcription factors and through changes in the eicosanoid profiles. Therefore, EPA may have beneficial effects on foetal heart, providing protection from a hyperglycaemic intrauterine environment in pregnant diabetic mothers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- IDMs:
-
Infants of diabetic mothers
- mTOR:
-
Mammalian target of rapamycin
- EPA:
-
Eicosapentaenoic acid
- DHA:
-
Docosahexaenoic acid
- PUFAs:
-
Polyunsaturated fatty acids
- PA:
-
Palmitic acid
- IRS:
-
Insulin receptor substrate
- GLUT4:
-
Glucose transporter type 4
- MAPK:
-
Mitogen-activated protein kinase
- JNK:
-
C-Jun N-terminal kinase
- ET-1:
-
Endothelin-1
- GPCR:
-
G protein-coupled receptor
- HUVEC:
-
Shuman umbilical vein endothelial cells
- TGF-β1:
-
Transforming growth factor β1
- NF-κB:
-
Nuclear factor κB
- TNF-α:
-
Tumour necrosis factor-α
- AMPK:
-
AMP-activated protein kinase
- TAK1:
-
TGF-β activated kinase-1
- FFAR4:
-
Free fatty acid receptor
References
Barker DJ, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993;10: 341(8850):938–41.
Driscoll SG, Benirschke K, Curtis GW. Neonatal deaths among infants of diabetic mothers. Postmortem findings in ninety-five infants. Am J Dis Child. 1960;100:818–35.
Hay WW Jr. Care of the infant of the diabetic mother. Curr Diab Rep. 2012;12(1):4–15.
Nasu-Kawaharada R, Nakamura A, Kakarla SK, et al. A maternal diet rich in fish oil may improve cardiac Akt-related signaling in the offspring of diabetic mother rats. Nutrition. 2013;29(4):688–92.
Food and Nutrition Board, Institute of Medicine. Dietary Fats: Total Fat and Fatty Acids. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: National Academies Press; 2002:422–541.
de Oliveira Otto MC, Mozaffarian D, Kromhout D, et al. Dietary intake of saturated fat by food source and incident cardiovascular disease: the multi-ethnic study of atherosclerosis. Am J Clin Nutr. 2012;96(2):397–404.
Kris-Etherton PM, Taylor DS, Yu-Poth S, et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000;71(1 Suppl):179S–88S.
Foreman-van Drongelen MMHP, Westdorp JM, van Houwelingen AC, et al. The essential fatty acid status of premature infants and the fatty acid composition of their diet. Am J Clin Nutr. 1993;57:829S.
Dyerberg J, Bang HO, Stoffersen E, et al. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978; 2(8081): 117–110.
Myhrstad MC, Retterstøl K, Telle-Hansen VH, et al. Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors. Inflamm Res. 2011;60:309–19.
Phang M, Garg ML, Sinclair AJ. Inhibition of platelet aggregation by omega-3 polyunsaturated fatty acids is gender specific-redefining platelet response to fish oils. Prostagland Leukotr Ess. 2009;81:35–40.
Marchioli R, Barzi F, Bomba E, et al. GISSI-Prevenzione Investigators.: early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time course analysis of the Gruppo Italiano per lo Stuio deela Sopravivenza nell’ Infarcto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897–903.
Yokoyama M, Origasa H, Matsuzaki M, et al. Japan EPA lipid intervention study (JELIS) Investigators: effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007; 31; 369 (9567): 1090–8.
Olsen SF, Østerdal ML, Salvig JD, et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring. 16 y of registry-based follow-up from a randomized controlled trial. Am J Clin Nutr. 2008;88:167–75.
Yang H, Xun P, He K. Fish and fish oil intake in relation to risk of asthma: a systematic review and meta-analysis. PLoS ONE. 2013;8:e80048.
Palmer DJ, Sullivan T, Gold MS, et al. Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants’ allergies in first year of life: randomised controlled trial. BMJ. 2012;30(344):e184.
Palmer DJ, Sullivan T, Gold MS, et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy. 2013;68(11):1370–6.
Dunstan JA, Simmer K, Dixon G, et al. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2008;93:F45–50.
Meldrum S, Dunstan JA, Foster JK, et al. Maternal fish oil supplementation in pregnancy: a 12 year follow-up of a randomised controlled trial. Nutrients. 2015;7:2061–7.
Rossi E, Costa M. Fish oil derivatives as a prophylaxis of recurrent miscarriage associated with antiphospholipid antibodies (APL): a pilot study. Lupus. 1993;2:319–23.
Lazzarin N, Vaquero E, Exacoustos C, et al. Low-dose aspirin and omega-3 fatty acids improve uterine artery blood flow velocity in women with recurrent miscarriage due to impaired uterine perfusion. Fertil Steril. 2009;92:296–300.
Salvig JD, Lamont RF. Evidence regarding an effect of marine n-3 fatty acids on preterm birth: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2011;90:825–38.
Carlson SE, Colombo J, Gajewski BJ, et al. DHA supplementation and pregnancy outcomes. Am J Clin Nutr. 2013;97(4):808–15.
The United Nations Inter-Agency Group for Child Mortality Estimation. http://www.childmortality.org. Accessed 9 Sept 2015.
Nasu R, Seki K, Nara M, et al. Effect of a high-fat diet on diabetic mother rats and their offspring through three generations. Endocr J. 2007;54(4):563–9.
Bertrand L, Horman S, Beauloye C, et al. Insulin signalling in the heart. Cardiovasc Res. 2008;79:238–48.
Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352: 837–53.
Bauer V, SotnÃková R. Nitric oxide the endothelium-derived relaxing factor and its role in endothelial functions. Gen Physiol Biophys. 2010;29:319–40.
Mitchell MD, Branch DW, Lamarche S, et al. The regulation of endothelin production in human umbilical vein endothelial cells: unique inhibitory action of calcium ionophores. J Clin Endocrinol Metab. 1992;75:665–8.
Yamazaki T, Komuro I, Kudoh S, et al. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem. 1996;271:3221–8.
Chisaki K, Okuda Y, Suzuki S, et al. Eicosapentaenoic acid suppresses basal and insulin-stimulated endothelin-1 production in human endothelial cells. Hypertens Res. 2003;26:655–61.
Shimojo N, Jesmin S, Zaedi S. Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK. Am J Physiol Heart Circ Physiol. 2006;291:H835–45.
Shimojo N, Jesmin S, Sakai S, et al. Fish oil constituent eicosapentaenoic acid inhibits endothelin-induced cardiomyocyte hypertrophy via PPAR-α. Life Sci. 2014;118:173–8.
Matsumoto T, Nakayama N, Ishida K, et al. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J Pharmacol Exp Ther. 2009;329:324–34.
Drosatos K, Schulze PC. Savings precede spending: fatty acid utilization relies on triglyceride formation for cardiac energetics. Circulation. 2014;130:1775–7.
Jové M, Planavila A, Sánchez RM, et al. Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappa B activation. Endocrinology. 2006;147:552–61.
Zhang J, Wu W, Li D, et al. Overactivation of NF-κB impairs insulin sensitivity and mediates palmitate-induced insulin resistance in C2C12 skeletal muscle cells. Endocrine. 2010;37:157–66.
Alvarez-Guardia D, Palomer X, Coll T, et al. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells. Biochim Biophys Acta. 2011;1811:59–67.
Wei CD, Li Y, Zheng HY, et al. Globular adiponectin protects H9c2 cells from palmitate-induced apoptosis via Akt and ERK1/2 signaling pathways. Lipids Health Dis. 2012;11:135.
Park M, Sabetski A, Kwan CY, et al. Palmitate induces ER stress and autophagy in H9c2 cells: implications for apoptosis and adiponectin resistance. J Cell Physiol. 2015;230:630–9.
Hsu HC, Chen CY, Lee BC, et al. High-fat diet induces cardiomyocyte apoptosis via the inhibition of autophagy. Eur J Nutr. 2016; 55:2245–54.
De Mello VD, Erkkilä AT, Schwab US, et al. The effect of fatty or lean fish intake on inflammatory gene expression in peripheral blood mononuclear cells of patients with coronary heart disease. Eur J Nutr. 2009;48:447–55.
Cetrullo S, Tantini B, Flamigni F, et al. Antiapoptotic and antiautophagic effects of eicosapentaenoic acid in cardiac myoblasts exposed to palmitic acid. Nutrients. 2012;4:78–90.
Hsu HC, Chen CY, Chiang CH, et al. Eicosapentaenoic acid attenuated oxidative stress-induced cardiomyoblast apoptosis by activating adaptive autophagy. Eur J Nutr. 2014;53:541–7.
Franekova V, Angin Y, Hoebers NT, et al. Marine omega-3 fatty acids prevent myocardial insulin resistance and metabolic remodeling as induced experimentally by high insulin exposure. Am J Physiol Cell Physiol. 2015;308:C297–307.
Talukdar S, Olefsky JM, Osborn O. Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol Sci. 2011;32: 543–50.
Kazemian P, Kazemi-Bajestani SM, Alherbish A, et al. The use of ω-3 poly-unsaturated fatty acids in heart failure: a preferential role in patients with diabetes. Cardiovasc Drugs Ther. 2012;26:311–20.
Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142:687–98.
Ichimura A, Hirasawa A, Poulain-Godefroy O, et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature. 2012;483:350–4.
Oh DY, Walenta E, Akiyama TE, et al. Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med. 2014;8:942–7.
Acknowledgements
This study was partially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15K00809 to AN and 26750054 to RK) and a grant from the Smoking Research Foundation (to AN).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Nakamura, A., Kawaharada, R. (2018). Fish Oil and Cardiac Akt/mTOR-Mediated Insulin Resistance in Infants with Maternal Diabetes. In: Rajendram, R., Preedy, V., Patel, V. (eds) Nutrition and Diet in Maternal Diabetes. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-56440-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-56440-1_14
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-56438-8
Online ISBN: 978-3-319-56440-1
eBook Packages: MedicineMedicine (R0)